Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes

Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population

(2015) Anping Cai et al.   BMC Cardiovascular Disorders

Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease

(2014) Otto Mayer et al.   European Journal of Internal Medicine

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

(2014) Michelle L. O’Donoghue et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipoprotein-Associated Phospholipase A2Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus

(2014) J. Fortunato et al.   Journal of Diabetes Research

Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes

(2013) Jose Sánchez-Quesada et al.   Cardiovascular Diabetology

Prevalence and Control of Diabetes in Chinese Adults

(2013) Yu Xu   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Lipoprotein-Associated Phospholipase A2(Lp-PLA2) and Future Risk of Type 2 Diabetes: Results from the Cardiovascular Health Study

(2012) T. L. Nelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

(2012) Robert S. Rosenson et al.   JOURNAL OF LIPID RESEARCH

Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome

(2011) Robert S. Rosenson et al.   CARDIOVASCULAR DRUGS AND THERAPY

Targeting Curcusomes to Inflammatory Dendritic Cells Inhibits NF-κB and Improves Insulin Resistance in Obese Mice

(2011) Suman Kumar Yekollu et al.   DIABETES

Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes

(2011) Alexander Constantinides et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Circulating Lipoprotein-associated Phospholipase A2 in High-grade Carotid Stenosis: A New Biomarker for Predicting Unstable Plaque

(2011) G. Sarlon-Bartoli et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice

(2011) Wen-yi Wang et al.   PLoS One

Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease

(2010) Ziad Mallat et al.   CIRCULATION

Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

(2010)   LANCET

The impact of family history of type 2 diabetes on pancreatic β-cell function

(2009) Zhi-hong Wang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

(2008) Jianping Weng et al.   LANCET

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

(2008) Robert L Wilensky et al.   NATURE MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: Relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment

(2007) Masanori Iwase et al.   ATHEROSCLEROSIS

Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration

(2007) N L A Misso et al.   THORAX